Breast Cancer Clinical Trial

Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters)

Summary

The purpose of this study is to test an evidence-based intervention designed to increase adherence to systemic therapy in Black women compared to enhanced usual care.

View Full Description

Full Description

Black women continue to experience worse breast cancer outcomes, which may be due to inadequate adherence to systemic therapies that can be improved via patient-centered communication. We developed and piloted the Sisters Informing SistersSM (SIS) intervention (survivor-led skill-building sessions and culturally tailored materials to activate Black breast cancer survivors in their medical encounters) and obtained promising findings. This project will compare in a two-arm RCT the impact of SIS vs. enhanced usual care (treatment recommendation summary form) on patient-centered communication and systemic treatment adherence; SIS tools may be integrated within existing clinical and support services.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Self-identify as Black
Newly diagnosed (~4 weeks post-definitive surgery and prior to initiation of adjuvant chemotherapy or endocrine therapy) patients (stage I-III)
Eligible for chemotherapy or endocrine therapy according to NCCN guidelines, but have not initiated systemic therapy
Ability to read and speak English
Ability to provide meaningful consent as determined by trained study personnel and/or a member of the patient's care team
No prior cancer treatment (other than skin cancer) in the two years preceding enrollment
Physicians Must be a license doctor of study patient(s)
Ability to speak English

Study is for people with:

Breast Cancer

Estimated Enrollment:

460

Study ID:

NCT05334732

Recruitment Status:

Recruiting

Sponsor:

Virginia Commonwealth University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Medstar Georgetown University Hospital
Washington District of Columbia, 20007, United States More Info
Hurtado de Mendoza
Contact
[email protected]
Lucile Adams-Campbell
Principal Investigator
Massey Cancer Center
Richmond Virginia, 23298, United States More Info
Vanessa B Sheppard, PhD
Contact
804-628-2700
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

460

Study ID:

NCT05334732

Recruitment Status:

Recruiting

Sponsor:


Virginia Commonwealth University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider